Obstetric antiphospholipid syndrome (OAPS), a representative autoimmune disorder driven by antiphospholipid antibodies (aPLs), afflicts 30% of patients with refractory to conventional antithrombotic treatment. Hydroxychloroquine (HCQ) offers adjunctive potential, yet its mechanistic action and critical treatment timing remain undefined. This study establishes the preventive efficacy of preconception HCQ initiation (HCQ-pre) and deciphers its fundamental rescue pathways in OAPS.
Results:
Clinical data suggested a potential advantage of HCQ-pre compared to post-conception administration (HCQ-post) in optimizing pregnancy outcomes for patients with OAPS. Modeling the pathology of OAPS using human trophoblast organoids revealed that HCQ-pre effectively reverses aPLs-mediated trophoblast dysfunction: increasing cytotrophoblast proliferation (Ki67+/TP63+) by 20% and restoring their differentiation into extravillous trophoblast (HLA-G+) to 93% of control levels, while HCQ-post shows markedly limited efficacy. Mechanistically, HCQ-pre preemptively corrected aPLs-induced redox imbalance by rescuing hypoxia-inducible factor 1-alpha-mediated hypoxia and replenishing antioxidant mediators (NRF2/SOD2/GPX4) via Hippo/YAP and Wnt/β-catenin signaling. Murine OAPS models established that HCQ-pre restores placental perfusion (90% of control levels) by enhancing spiral artery remodeling—with diminished efficacy observed at post-conception administration—thereby attenuating hypoperfusion-induced hypoxic damage and improving pregnancy outcomes.
Innovation and Conclusions:
We redefine HCQ as a proactive placental resetter that neutralizes oxidative stress barriers preconception, thereby liberating trophoblast differentiation capacity. This work positions HCQ-pre as the critical intervention phase—a paradigm shift from reactive adjunct to preemptive root-cause interception, providing the mechanistic foundation for optimizing OAPS management through timely individualized prophylaxis. Antioxid. Redox Signal. 44, 748–769.
Alijotas-ReigJ, Ferrer-OliverasR, RuffattiA, et al.; (EUROAPS Study Group Collaborators). The European registry on obstetric antiphospholipid syndrome (EUROAPS): A survey of 247 consecutive cases. Autoimmun Rev, 2015; 14(5):387–395; doi: 10.1016/j.autrev.2014.12.010
2.
AmbatiA, KnightJS, ZuoY. Antiphospholipid syndrome management: A 2023 update and practical algorithm-based approach. Curr Opin Rheumatol, 2023; 35(3):149–160; doi: 10.1097/BOR.0000000000000932
3.
ArachchillageDJ, LaffanM, PericleousC. Hydroxychloroquine as an immunomodulatory and antithrombotic treatment in antiphospholipid syndrome. Int J Mol Sci, 2023; 24(2):1331; doi: 10.3390/ijms24021331
4.
BagchiIC, BagchiMK. Maternal-fetal mechanisms underlying adaptation to hypoxia during early pregnancy. Trends Endocrinol Metab, 2024; 35(12):1091–1099; doi: 10.1016/j.tem.2024.07.006
5.
BasriNI, MurthiP, Abd RahmanR. Hydroxychloroquine as an adjunct therapy for diabetes in pregnancy. Int J Mol Sci, 2024; 25(17):9681; doi: 10.3390/ijms25179681
6.
BertolacciniML, ContentoG, LennenR, et al.Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome. J Autoimmun, 2016; 75:30–38; doi: 10.1016/j.jaut.2016.04.008
7.
BoseP, KadyrovM, GoldinR, et al.Aberrations of early trophoblast differentiation predispose to pregnancy failure: Lessons from the anti-phospholipid syndrome. Placenta, 2006; 27(8):869–875; doi: 10.1016/j.placenta.2005.09.007
8.
ChoiM, ByunN, HwangJR, et al.Effect of hydroxychloroquine and chloroquine on syncytial differentiation and autophagy in primary human trophoblasts. Biomed Pharmacother, 2022; 149:112916; doi: 10.1016/j.biopha.2022.112916
9.
CuiP, ZhangP, YuanL, et al.HIF-1alpha affects the neural stem cell differentiation of human induced pluripotent stem cells via MFN2-mediated Wnt/beta-catenin signaling. Front Cell Dev Biol, 2021; 9:671704; doi: 10.3389/fcell.2021.671704
10.
D’IppolitoS, BarbaroG, PaciulloC, et al.Antiphospholipid syndrome in pregnancy: New and old pathogenetic mechanisms. Int J Mol Sci, 2023; 24(4):3195; doi: 10.3390/ijms24043195
11.
DernoncourtA, HedhliK, AbisrorN, et al.Hydroxychloroquine in recurrent pregnancy loss: Data from a French prospective multicenter registry. Hum Reprod, 2024; 39(9):1934–1941; doi: 10.1093/humrep/deae146
12.
DevarajanA, VaseghiM. Hydroxychloroquine can potentially interfere with immune function in COVID-19 patients: Mechanisms and insights. Redox Biol, 2021; 38(0):101810; doi: 10.1016/j.redox.2020.101810
13.
DeyA, VarelasX, GuanKL. Targeting the hippo pathway in cancer, fibrosis, wound healing and regenerative medicine. Nat Rev Drug Discov, 2020; 19(7):480–494; doi: 10.1038/s41573-020-0070-z
14.
DietrichB, HaiderS, MeinhardtG, et al.WNT and NOTCH signaling in human trophoblast development and differentiation. Cell Mol Life Sci, 2022; 79(6):292; doi: 10.1007/s00018-022-04285-3
15.
FanouriakisA, KostopoulouM, AlunnoA, et al.2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis, 2019; 78(6):736–745; doi: 10.1136/annrheumdis-2019-215089
16.
GamageSMK, LeeKTW, DissabandaraDLOet al.Dual role of heme iron in cancer; promotor of carcinogenesis and an inducer of tumour suppression. Exp Mol Pathol, 2021; 120:104642; doi: 10.1016/j.yexmp.2021.104642
17.
GeoffreyU, AntoineC, CarolineP, et al.Hydroxychloroquine partially prevents endothelial dysfunction induced by anti-beta-2-GPI antibodies in an in vivo mouse model of antiphospholipid syndrome. PLoS One, 2018; 13(11); doi: 10.1371/journal.pone.0206814
18.
GerdeM, IbarraE, Mac KenzieR, et al.The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome. Thromb Res, 2021; 206:104–110; doi: 10.1016/j.thromres.2021.08.004
19.
HembergerM, HannaCW, DeanW. Mechanisms of early placental development in mouse and humans. Nat Rev Genet, 2020; 21(1):27–43; doi: 10.1038/s41576-019-0169-4
20.
HooperA, BacalV, BedaiwyMA. Does adding hydroxychloroquine to empiric treatment improve the live birth rate in refractory obstetrical antiphospholipid syndrome? A systematic review. Am J Reprod Immunol, 2023; 90(3):e13761; doi: 10.1111/aji.13761
21.
HuangZ, TangZ, GuanH, et al.Inactivation of yes-associated protein mediates trophoblast dysfunction: A new mechanism of pregnancy loss associated with anti-phospholipid antibodies? Biomedicines, 2022; 10(12):3296; doi: 10.3390/biomedicines10123296
22.
HuoR, SunQ, LvQ, et al.Simvastatin ameliorates adverse pregnancy by inhibiting glycolysis-related NETs in obstetrical antiphospholipid syndrome. Life Sci, 2024; 359(0):123215; doi: 10.1016/j.lfs.2024.123215
23.
JiangN, ZhaoH, HanY, et al.HIF-1alpha ameliorates tubular injury in diabetic nephropathy via HO-1-mediated control of mitochondrial dynamics. Cell Prolif, 2020; 53(11):e12909; doi: 10.1111/cpr.12909
24.
KanekoK, OzawaN, MurashimaA. Obstetric anti-phospholipid syndrome: From pathogenesis to treatment. Immunol Med, 2022; 45(2):79–93; doi: 10.1080/25785826.2021.1969116
25.
LiliC, ZhipengW, ShiQ, et al.LC-MS/MS method for determination of hydroxychloroquine and metabolites: Application in a pharmacokinetic study. J Anal Methods Chem, 2022; 2022(0); doi: 10.1155/2022/6058445
26.
LiuJ, ZhangL, TianY, et al.Protection by hydroxychloroquine prevents placental injury in obstetric antiphospholipid syndrome. J Cell Mol Med, 2022; 26(15):4357–4370; doi: 10.1111/jcmm.17459
27.
MarchettiT, RuffattiA, WuilleminC, et al.Hydroxychloroquine restores trophoblast fusion affected by antiphospholipid antibodies. J Thromb Haemost, 2014; 12(6):910–920; doi: 10.1111/jth.12570
28.
McCarthyCG, WenceslauCF, GoulopoulouS, et al.Autoimmune therapeutic chloroquine lowers blood pressure and improves endothelial function in spontaneously hypertensive rats. Pharmacol Res, 2016; 113(Pt A):384–394; doi: 10.1016/j.phrs.2016.09.008
29.
MiyakisS, LockshinMD, AtsumiT, et al.International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost, 2006; 4(2):295–306; doi: 10.1111/j.1538-7836.2006.01753.x
30.
OkaeH, TohH, SatoT, et al.Derivation of human trophoblast stem cells. Cell Stem Cell, 2018; 22(1):50–63.e56; doi: 10.1016/j.stem.2017.11.004
31.
PascualF. Trophoblast organoids: A new tool for studying placental development. Environ Health Perspect, 2022; 130(5):54003; doi: 10.1289/EHP11351
32.
QingfengL, YuanW, WeiT, et al.Exosomal miR-146a-5p derived from human umbilical cord mesenchymal stem cells can alleviate antiphospholipid antibody-induced trophoblast injury and placental dysfunction by regulating the TRAF6/NF-κB axis. J Nanobiotechnology, 2023; 21(1); doi: 10.1186/s12951-023-02179-5
33.
RayS, SahaA, GhoshA, et al.Hippo signaling cofactor, WWTR1, at the crossroads of human trophoblast progenitor self-renewal and differentiation. Proc Natl Acad Sci U S A, 2022; 119(36):e2204069119; doi: 10.1073/pnas.2204069119
34.
SandraH, GudrunM, PhilippV, et al.Notch signaling plays a critical role in motility and differentiation of human first-trimester cytotrophoblasts. Endocrinology, 2013; 155(1); doi: 10.1210/en.2013-1455
35.
SciasciaS, HuntBJ, Talavera-GarciaE, et al.The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies. Am J Obstet Gynecol, 2016; 214(2):273.e1–273.e8; doi: 10.1016/j.ajog.2015.09.078
36.
SheridanMA, FernandoRC, GardnerL, et al.Establishment and differentiation of long-term trophoblast organoid cultures from the human placenta. Nat Protoc, 2020; 15(10):3441–3463; doi: 10.1038/s41596-020-0381-x
37.
ShiJ, YuT, SongK, et al.Dexmedetomidine ameliorates endotoxin-induced acute lung injury in vivo and in vitro by preserving mitochondrial dynamic equilibrium through the HIF-1a/HO-1 signaling pathway. Redox Biol, 2021; 41:101954; doi: 10.1016/j.redox.2021.101954
SomersEC. Pregnancy and autoimmune diseases. Best Pract Res Clin Obstet Gynaecol, 2020; 64:3–10; doi: 10.1016/j.bpobgyn.2019.11.004
40.
SoncinF, ParastMM. Role of hippo signaling pathway in early placental development. Proc Natl Acad Sci U S A, 2020; 117(34):20354–20356; doi: 10.1073/pnas.2013559117
41.
TektonidouMG, AndreoliL, LimperM, et al.EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis, 2019; 78(10):1296–1304; doi: 10.1136/annrheumdis-2019-215213
42.
TianY, XuJ, ChenD, et al.The additional use of hydroxychloroquine can improve the live birth rate in pregnant women with persistent positive antiphospholipid antibodies: A systematic review and meta-analysis. J Gynecol Obstet Hum Reprod, 2021; 50(8):102121; doi: 10.1016/j.jogoh.2021.102121
43.
TranV, WeckmanAM, CrowleyVM, et al.The Angiopoietin-Tie2 axis contributes to placental vascular disruption and adverse birth outcomes in malaria in pregnancy. EBioMedicine, 2021; 73(0):103683; doi: 10.1016/j.ebiom.2021.103683
44.
TurcoMY, GardnerL, KayRG, et al.Trophoblast organoids as a model for maternal-fetal interactions during human placentation. Nature, 2018; 564(7735):263–267; doi: 10.1038/s41586-018-0753-3
45.
UrbanskiG, CaillonA, PoliC, et al.Hydroxychloroquine partially prevents endothelial dysfunction induced by anti-beta-2-GPI antibodies in an in vivo mouse model of antiphospholipid syndrome. PLoS One, 2018; 13(11):e0206814; doi: 10.1371/journal.pone.0206814
46.
VornicI, NesiuA, ArdeleanAM, et al.Antioxidant defenses, oxidative stress responses, and apoptosis modulation in spontaneous abortion: An immunohistochemistry analysis of first-trimester chorionic villi. Life (Basel), 2024; 14(9):1074; doi: 10.3390/life14091074
47.
WuY, WangJ, ZhaoT, et al.Di-(2-ethylhexyl) phthalate exposure leads to ferroptosis via the HIF-1alpha/HO-1 signaling pathway in mouse testes. J Hazard Mater, 2022; 426:127807; doi: 10.1016/j.jhazmat.2021.127807
48.
YangY, JiangH, TangZ, et al.Assessment of the 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Chinese cohort: Impact on clinical practice. J Autoimmun, 2024; 146:103237; doi: 10.1016/j.jaut.2024.103237
49.
YashpalSC, RichardLS, JingL, et al.Simultaneous quantitation of hydroxychloroquine and its metabolites in mouse blood and tissues using LC-ESI-MS/MS: An application for pharmacokinetic studies. J Chromatogr B Analyt Technol Biomed Life Sci, 2017; 1072(0); doi: 10.1016/j.jchromb.2017.11.026
50.
Yoo-MinK, Ji-HeeS, Hyun-HwaC, et al.Hydroxychloroquine in obstetrics: Potential implications of the prophylactic use of hydroxychloroquine for placental insufficiency during pregnancy. Obstet Gynecol Sci, 2024; 67(2); doi: 10.5468/ogs.23252
51.
YuH, YangZ, DingX, et al.Effects of serum from patients with early-onset pre-eclampsia, HELLP syndrome, and antiphospholipid syndrome on fatty acid oxidation in trophoblast cells. Arch Gynecol Obstet, 2015; 292(3):559–567; doi: 10.1007/s00404-015-3669-2
52.
ZhangH, HeH, CuiY, et al.Regulatory effects of HIF-1alpha and HO-1 in hypoxia-induced proliferation of pulmonary arterial smooth muscle cells in yak. Cell Signal, 2021; 87:110140; doi: 10.1016/j.cellsig.2021.110140
53.
ZhangQ, LeeCL, YangT, et al.Adrenomedullin has a pivotal role in trophoblast differentiation: A promising nanotechnology-based therapeutic target for early-onset preeclampsia. Sci Adv, 2023; 9(44):eadi4777; doi: 10.1126/sciadv.adi4777
54.
ZhaoM, LeiJ, DengF, et al.Gestational hypoxia impaired endothelial nitric oxide synthesis via miR-155-5p/NADPH oxidase/reactive oxygen species axis in male offspring vessels. J Am Heart Assoc, 2024; 13(3):e032079; doi: 10.1161/JAHA.123.032079
55.
ZhuY, WuF, HuJ, et al.LDHA deficiency inhibits trophoblast proliferation via the PI3K/AKT/FOXO1/CyclinD1 signaling pathway in unexplained recurrent spontaneous abortion. Faseb J, 2023; 37(2):e22744; doi: 10.1096/fj.202201219RR
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
